PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1987; 80(Suppl 15): 47–50.
PMCID: PMC1290613

The difficulties of treating cystic fibrosis in adults.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (935K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lamb SM, David TJ. Playing with fire: an experiment in clinical budgeting. Br Med J (Clin Res Ed) 1985 Feb 23;290(6468):650–651. [PMC free article] [PubMed]
  • O'Neill PA, Dodds M, Phillips B, Poole J, Webb AK. Regular exercise and reduction of breathlessness in patients with cystic fibrosis. Br J Dis Chest. 1987 Jan;81(1):62–69. [PubMed]
  • Szaff M, Høiby N, Flensborg EW. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983 Sep;72(5):651–657. [PubMed]
  • Pedersen SS, Koch C, Høiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother. 1986 Apr;17(4):505–516. [PubMed]
  • Speert DP, Campbell ME. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J Hosp Infect. 1987 Jan;9(1):11–21. [PubMed]
  • Scully BE, Neu HC, Parry MF, Mandell W. Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa. Lancet. 1986 Apr 12;1(8485):819–822. [PubMed]
  • Hodson ME, Roberts CM, Butland RJ, Smith MJ, Batten JC. Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet. 1987 Jan 31;1(8527):235–237. [PubMed]
  • Penketh A, Pitt T, Roberts D, Hodson ME, Batten JC. The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis. 1983 May;127(5):605–608. [PubMed]
  • Thomassen MJ, Demko CA, Klinger JD, Stern RC. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis. 1985 May;131(5):791–796. [PubMed]
  • Spino M, Chai RP, Isles AF, Balfe JW, Brown RG, Thiessen JJ, MacLeod SM. Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis. J Pediatr. 1985 Jul;107(1):64–70. [PubMed]
  • Penketh AR, Knight RK, Hodson ME, Batten JC. Management of pneumothorax in adults with cystic fibrosis. Thorax. 1982 Nov;37(11):850–853. [PMC free article] [PubMed]
  • Auerbach HS, Williams M, Kirkpatrick JA, Colten HR. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet. 1985 Sep 28;2(8457):686–688. [PubMed]
  • Stern RC, Rothstein FC, Doershuk CF. Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1986 Jan;5(1):35–40. [PubMed]
  • Phillips BM, David TJ. Pathogenesis and management of arthropathy in cystic fibrosis. J R Soc Med. 1986;79 (Suppl 12):44–50. [PMC free article] [PubMed]
  • Pinkerton P, Trauer T, Duncan F, Hodson ME, Batten JC. Cystic fibrosis in adult life: a study of coping patterns. Lancet. 1985 Oct 5;2(8458):761–763. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press